NR0B2 Antibody, FITC conjugated

說明書

中文名稱：

NR0B2兔多克隆抗體, FITC偶聯
貨號：

CSB-PA624025LC01HU
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) NR0B2 Polyclonal antibody
Uniprot No.：

Q15466
基因名：

NR0B2
別名：

NR0B2 antibody; NR0B2_HUMAN antibody; Nr0b2a antibody; Nuclear receptor subfamily 0 group B member 2 antibody; Nuclear receptor subfamily 0; group B; member 2a antibody; Orphan nuclear receptor SHP antibody; SHP antibody; SHP-1 antibody; Shp1 antibody; Small heterodimer partner antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Nuclear receptor subfamily 0 group B member 2 protein (1-257AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Transcriptional regulator that acts as a negative regulator of receptor-dependent signaling pathways. Specifically inhibits transactivation of the nuclear receptor with which it interacts. Inhibits transcriptional activity of NEUROD1 on E-box-containing promoter by interfering with the coactivation function of the p300/CBP-mediated transcription complex for NEUROD1. Essential component of the liver circadian clock which via its interaction with NR1D1 and RORG regulates NPAS2-mediated hepatic lipid metabolism. Regulates the circadian expression of cytochrome P450 (CYP) enzymes. Represses: NR5A2 and HNF4A to down-regulate CYP2C38, NFLI3 to up-regulate CYP2A5, BHLHE41/HNF1A axis to up-regulate CYP1A2, CYP2E1 and CYP3A11, and NR1D1 to up-regulate CYP2B10, CYP4A10 and CYP4A14.
基因功能參考文獻：
1. results suggest that NR0B2 is a tumor suppressor gene in ccRCC, and that the hypermethylation of promoter region is the main mechanism of its downregulation. PMID: 29989580
2. DDX3 regulates MTP gene expression and lipid homeostasis through interplay with HNF4 and SHP. PMID: 28128295
3. The miR-141 was significantly up-regulated in the samples of metastatic tumors compared to localized tumor samples. Tumor samples showed lower SHP mRNA expression levels than BPH samples. PMID: 29562494
4. The impact of these variants on transactivation of the NR0B2 promoter by NRs known to be regulators of SHP1 expression was assessed in a cell-based reporter gene assay, showing that transactivation by hepatocyte nuclear factor 4alpha and liver receptor homolog-1 was significantly decreased in the presence of the genetic variant NR0B2:c.-594T> PMID: 28873070
5. Data indicate a functional interaction between small heterodimer partner protein SHP1 and hepatitis C virus (HCV) NS5A protein. PMID: 27661118
6. This study was performed to test the hypothesis that the SHP gene is a target gene of DEC1. Cotransfection demonstrated that DEC1 repressed the SHP promoter and attenuated the transactivation of the classic circadian activator complex of Clock/Bmal1. PMID: 28797635
7. The molecular dynamics and structural analysis of the small heterodimer partner in complex with glucocorticoid receptor is described. PMID: 28396564
8. The finding that overexpression of HIF-1alpha increased the activity of the CYP7A1 promoter suggested that hypoxia decreased the expression of CYP7A1 in a HIF-1-independent manner. PMID: 26521940
9. Results demonstrated a detrimental effect of Bcl2 and H19 associated with cholestatic liver fibrosis and an indispensable role of Shp to maintain normal liver function. PMID: 26838806
10. These findings show that POD-1/TCF21 regulates SF-1 and LRH-1 by distinct mechanisms, contributing to the understanding of POD-1 involvement and its mechanisms of action in adrenal and liver tumorigenesis. PMID: 26421305
11. Overexpression of SHP and activation of AMPK reverses profibrogenic features of HCV-infected cells by decreasing TGF-beta and fibrotic gene expression. PMID: 25976932
12. Data suggest that LRH1/NR5A2 (liver receptor homologue-1) exhibits phospholipid-mediated allosteric control of protein-protein binding interface in interactions with TIF2 (co-activator; transcription intermediary factor 2) and SHP. PMID: 26553876
13. At the molecular level, estrogen upregulated hepatic SHP expression through binding to its proximal promoter. In addition, the roles of estrogen were largely blunted in mice with SHP deficiency. PMID: 25720568
14. These data are suggestive of a role for SHP in controlling NLRP3 inflammasome activation through a mechanism involving interaction with NLRP3 and maintenance of mitochondrial homeostasis. PMID: 25655831
15. These results establish SHP as a novel antihypertrophic regulator that acts by interfering with GATA6 signaling. PMID: 25015078
16. E2F1 transcription factor activates early growth response (Egr)-1 promoter which is repressed by SHP and EIA-like inhibitor of differentiation (EID)1. PMID: 24619556
17. SHP regulates PDCD5-mediated apoptosis in cancer cells PMID: 24343129
18. SHP repressed HNF4alpha transactivation of CYP2D6 promoter. PMID: 24318876
19. An unexpected EID1-binding site on SHP is located at the N terminus of the receptor, where EID1 mimics helix H1 of the nuclear receptor ligand-binding domain. PMID: 24379397
20. These results indicate that the N-terminal domain of SHP is important for its nuclear translocation via HNF4alpha. PMID: 23874642
21. This study identifies PKCzeta as a novel key upstream regulator of BA-regulated SHP function, revealing the role of Thr-55 phosphorylation in epigenomic regulation of liver metabolism. PMID: 23824184
22. HNF4alpha and LRH-1 promote active transcription histone marks on the Cyp7a1 promoter that are reversed by FGF19 in a SHP-dependent manner PMID: 23038264
23. SHP is a downstream factor of BMP2 signaling in odontoblasts and may stimulate dentin matrix mineralization via enhancing the transcriptional activity of Dlx5. PMID: 23010719
24. Lentivirus-mediated exogenous FXR expression resulted in a marked increase of small heterodimer partner expression, significant repression of liver cancer cell proliferation. PMID: 23042943
25. Shp is a target for miR-141 and it is downregulated in cultured human PCa cells with the involvement of upregulation of miR-141, which promotes AR transcriptional activity. PMID: 22314666
26. NR0B2 physically interacted with STAT5 and inhibited STAT5 recruitment on the PEPCK gene promoter. PMID: 22977252
27. Overexpression of p53 causes rapid SHP protein degradation, which does not require the presence of Mdm2 and is mediated by the proteosome pathway PMID: 22737255
28. In human hepatocellular carcinoma, increased DNMT1 expression is negatively correlated with SHP levels. PMID: 22362755
29. The impact of loss of SHP protein may be even more pronounced in fibrolamellar carcinoma than in a typical form of hepatocellular carcinoma. PMID: 22292081
30. FXR and SHP play a limited role in modulating HBV biosynthesis. PMID: 22171277
31. control network for Egr-1 expression through a feedback loop between SHP and HNF4alpha. PMID: 21725089
32. Study provides evidence for nuclear receptor mediated regulation of Dnmt1 expression through ERRgamma and SHP crosstalk. PMID: 21459093
33. The activity of SHP is also increased by posttranslational methylation at Arg-57 by protein arginine methyltransferase 5 (PRMT5). PMID: 21262773
34. NR0B2/SHP expression level was significantly decreased in human liver cancer but not in normal liver PMID: 20853064
35. mutagenesis experiments whose preliminary data suggest the presence of a functional site in SHP as defined by residues Phe96, Arg138 and Arg238 PMID: 20882396
36. genetic variations in SHP are common among human subjects; the Lys-170 residue plays a key role in controlling SHP ubiquitination and acetylation associated with SHP protein stability and repressive function PMID: 20516075
37. Mutations of the small heterodimer partner gene is associated with obesity and type 2 diabetes. PMID: 20233523
38. SHP overexpression decreased the expression of Gli target genes and SHP knockdown increased the expression of these genes. The results suggest that SHP can play a negative role in Hedgehog/Gli1 signalling. PMID: 20175750
39. polymorphisms in the human SHP1 gene; found no rare SHP1 coding sequence variants that were exclusive to patients with lipodystrophy PMID: 12181644
40. SHP is able to interact with LXR and to modulate its transcriptional activity. PMID: 12198243
41. SHP has a role in modulating hepatic glucocorticoid action PMID: 12324453
42. the relation between genetic variation in SHP and birth weight, adiposity, and insulin levels in three independent populations PMID: 12716767
43. orphan receptor small heterodimer partner expression is regulated by estrogen receptor alpha PMID: 12842887
44. Modulation of SHP expression and/or activity in adipose tissue may therefore have significant effects on aromatase expression and estrogen production in breast adipose tissue. PMID: 14593077
45. basic helix-loop-helix (bHLH) transcription factors, the E2A proteins (E47, E12 and E2/5), activated the human but not the mouse SHP promoter PMID: 14627819
46. results suggest that bile acids negatively regulate the human angiotensinogen gene through the inhibitory effect of small heterodimer partner on hepatocyte nuclear factor-4 PMID: 14672953
47. Acts as a novel corepressor for basic helix-loop-helix transcription factor BETA2/NeuroD PMID: 14752053
48. At diagnosis, methylation of SHP1 occurred more frequently in acute myeloid leukaemia than acute lymphoblastic leukaemia. Frequent methylation of SHP1, but not SOCS1, may be important in the pathogenesis, but not prognosis, of acute leukaemias PMID: 14762685
49. orphan nuclear receptor small heterodimer partner promoter is regulated by sterol regulatory element binding protein-1 PMID: 15123650
50. PGC-1alpha mediates the ligand-dependent activation of FXR and transcription of SHP gene. PMID: 15202934
顯示更多

收起更多
相關疾病：

Obesity (OBESITY)
亞細胞定位：

Nucleus. Cytoplasm. Note=Colocalizes with NEUROD1 in the nucleus.
蛋白家族：

Nuclear hormone receptor family, NR0 subfamily
組織特異性：

Liver. Low levels of expression were detected in heart and pancreas.
數據庫鏈接：

HGNC: 7961

OMIM: 601665

KEGG: hsa:8431

STRING: 9606.ENSP00000254227

UniGene: Hs.427055

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human